Science & Research

OWH Research and Development Program

The FDA Office of Women’s Health (OWH) Research and Development Program supports scientific research and workshops that:

  • advocate for the inclusion of women in clinical trials and data analyses by sex.
  • look for potential sex-based differences in the safety and efficacy of FDA-regulated medical products.
  • promote a better understanding of health conditions that solely or disproportionately affect women.

OWH Research Activities

  • Intramural Research Program - OWH provides research grants to FDA scientists to develop projects that address regulatory research questions related to sex differences and other women’s health issues. Grants are approximately $100,000 - $150,000 for 1-2 year studies. View a list of Intramural Research Grants by Funding Year or by Therapeutic Category
  • Extramural Research Collaborations - OWH collaborates with other government agencies and private partners to address regulatory research questions that require technology, expertise or resources outside the agency.
  • Special Funding Initiatives – OWH funds projects that rapidly respond to emerging or under-studied women’s health issues. OWH has used Special Funding Initiatives to fund workshops and conduct analytical surveys.

Visit the “Research Initiatives” page to learn more about OWH research efforts.

OWH Resarch Summary Reports

OWH Leadership

  • Marsha Henderson, MCRP - Assistant Commissioner for Women’s Health
  • Pamela Scott, PhD - Director of Research and Development

Contact FDA

Food and Drug Administration Office of Women's Health

10903 New Hampshire Avenue


Silver Spring, MD 20993

Page Last Updated: 09/08/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.